Olfactomics is a Finnish university-based spinoff company developing a novel technology for surgical tissue assessment.
We focus on improving breast-concerving lumpectomies where residual tumor continues to be an issue. Realtime tissue analysis allows the surgeon to remove the whole tumor in one operation and minimize the resection of healthy tissues.
Our goal is to save 100 000 women from unnecessary reoperations and one billion dollars in healthcare costs.
The heart of Olfactomics' technology is a differential ion mobility spectrometry (DMS) sensor. Unlike traditional mass spectrometry, DMS does not require vacuum, and it reduces costs and maintenance burdren to a fraction.
The system consists of sample preparation, sensor and data analysis, leading to diagnosis. The pinciple is very similar to the way we humans use our olfaction to our advantage:
Through a decade of research, Olfactomics' team has succeeded to make key breakthoughs in sample preparation, allowing rapid analysis of gas mixtures that were previously unfeasible, at an affordable cost.
The foundation of our company is the scientific method. In references you will find selected publications from our team. Several papers on the Olfactomics' surgical technology are currently under review.
Our team is characterized by a close connection between the clinic, the university, engineering and business professionals.
The practising surgeons of our team constantly spar ideas with our engineering team, resulting in agile, clinic-driven development.
We work closely with medical device manufacturers, sensor companies and the software industry to create maximum accuracy, reliability and value.
A research paper by Anton Kontunen describing differential mobility spectrometry was published on highly regarded Annals of Biomedical Engineering!Read more: Annals of Biomedical Engineering
An oral presentation on the results acquired with Olfactomics technology in breast cancer were presented at The Operative days of the Finnish Society of Surgery.Read more: Finnish Society of Surgery
Olfactomics is now part of Stanford-bred medtech incubator.Read more: SPARK Finland - New SPARKees join the program
MSc Anton Kontunen explains how surgical smoke can tell whether the tissue is cancerous or not.Read more: Interface science magazine - Electronic nose `smells` cancer
Professor Jouko Vepsäinen from University of Eastern Finland discusses the smell of cancer, the molecules behind it. The detection of prostate cancer by eNose is pointed out.Read more: UEF bulletin - What does cancer smell like?
"A joint project between researchers at the University of Tampere and Tampere University of Technology has resulted in the development of an electronic nose, which is capable of detecting pathogens that cause urinary tract infections."
Read the whole article from Medscape
"It is always humbling to see how much you can miss in trying to keep up with medicine's developments, even in an incredibly narrow area like prostate cancer."
Read the whole article from Asco Connection
Scientific results are the basis of our operation.
Kontunen A, Karjalainen M, Lekkala J, Roine A, Oksala N.
Ann Biomed Eng. First Online: 24 April 2018. doi: https://doi.org/10.1007/s10439-018-2035-5.
Saviauk T, Kiiski JP, Nieminen MK, Tamminen NN, Roine AN, Kumpulainen PS, Hokkinen LJ, Karjalainen MT, Vuento RE, Aittoniemi JJ, Lehtimäki TJ, Oksala NK.
Eur Surg Res. 2018 Jan 10;59(1-2):1-11. doi: 10.1159/000485461.
Roine A, Saviauk T, Kumpulainen P, Karjalainen M, Tuokko A, Aittoniemi J, Vuento R, Lekkala J, Lehtimäki T, Tammela TL, Oksala NK.
PLoS One. 2014 Dec 19;9(12):e114279. doi: 10.1371/journal.pone.0114279.
Roine A, Veskimäe E, Tuokko A, Kumpulainen P, Koskimäki J, Keinänen TA, Häkkinen MR, Vepsäläinen J, Paavonen T, Lekkala J, Lehtimäki T, Tammela TL, Oksala NK.
J Urol. 2014 Jul;192(1):230-4. doi: 10.1016/j.juro.2014.01.113.
Roine A, Tolvanen M, Sipiläinen M, Kumpulainen P, Helenius MA, Lehtimäki T, Vepsäläinen J, Keinänen TA, Häkkinen MR, Koskimäki J, Veskimäe E, Tuokko A, Visakorpi T, Tammela TL, Sioris T, Paavonen T, Lekkala J, Helle H, Oksala NK.
Future Oncol. 2012 Sep;8(9):1157-65. doi: 10.2217/fon.12.93.
We work closely with the academic and industrial sectors.
Want to hear more about us? Are You the missing link in our growing team of professionals? Don't hesitate to contact us! Please fill out the form and we will be in touch.